Concept of atherosclerosis velocity: is it a better measure of cardiovascular risk?

Seyyed Mohammad Reza Kazemi-Bajestani1, Majid Ghayour-Mobarhan

  • 1Cardiovascular Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Atherosclerosis velocity, a new term, quantifies the speed of atherosclerosis progression. Understanding this time-dependent factor is crucial for managing vascular diseases like heart disease and stroke.

Area of Science:

  • Cardiovascular Science
  • Pathology
  • Medical Research

Background:

  • Atherosclerosis is the primary cause of vascular diseases, including heart disease and stroke.
  • Endothelial injury is recognized as the earliest arterial wall alteration preceding atherosclerotic lesion development.
  • Recent research highlights the significance of the time parameter in atherosclerosis progression.

Purpose of the Study:

  • To introduce and define the novel concept of "atherosclerosis velocity."
  • To review existing evidence related to atherosclerosis velocity.
  • To discuss the clinical importance of quantifying atherosclerosis progression rate.

Main Methods:

  • Literature review of existing studies on atherosclerosis progression.
  • Analysis of factors influencing the time-dependent rate of atherosclerosis.
  • Synthesis of evidence to support the concept of atherosclerosis velocity.

Main Results:

  • Atherosclerosis velocity is proposed as a key parameter for understanding disease progression.
  • Time-dependent factors significantly influence the rate at which atherosclerosis develops.
  • Quantifying atherosclerosis velocity offers new insights into vascular disease development.

Conclusions:

  • The concept of atherosclerosis velocity provides a novel framework for studying atherosclerosis.
  • Understanding atherosclerosis velocity is essential for predicting and managing vascular diseases.
  • Further research into atherosclerosis velocity may lead to improved diagnostic and therapeutic strategies.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
14.5K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Velocity of an Object01:18

Velocity of an Object

Understanding how an object moves along a path requires distinguishing between motion over a time span and motion at a precise moment. A useful example is a vehicle traveling along a straight and level path, where its position at any given time is known. The initial step in analyzing this motion is to measure how far the vehicle travels over a fixed time period. This measurement, called average velocity, is computed by dividing the total change in position by the duration over which the change...
306